Tokyo, Japan

Jun Chiba

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 94(Granted Patents)


Location History:

  • Edogawa-ku, JP (2012)
  • Tokyo, JP (2004 - 2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Jun Chiba: Innovator in Pharmaceutical Chemistry

Introduction

Jun Chiba is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target lymphocyte regulation. With a total of 6 patents to his name, Chiba's work is recognized for its potential therapeutic applications.

Latest Patents

Chiba's latest patents include innovative compounds such as phosphoric acid ester derivatives. These compounds are designed to provide a novel solution with S1P lyase inhibitory ability, which induces a reduction in the number of lymphocytes. Additionally, he has developed imidazole derivatives that also exhibit S1P lyase inhibitory capacity, further contributing to the understanding of lymphocyte regulation in pharmaceutical applications.

Career Highlights

Throughout his career, Jun Chiba has worked with notable companies in the pharmaceutical industry, including Daiichi Sankyo Company, Limited and Daiichi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Chiba has collaborated with esteemed colleagues such as Nobuo Machinaga and Atsushi Nakayama. These partnerships have fostered a collaborative environment that enhances innovation and drives forward the research in pharmaceutical chemistry.

Conclusion

Jun Chiba's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for advancements in therapeutic solutions targeting lymphocyte regulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…